Erythromycin Ethyl Succinate BP/USP represents a premium macrolide antibiotic active pharmaceutical ingredient manufactured to exacting British Pharmacopoeia and United States Phar...

Erythromycin Ethyl Succinate BP/USP represents a premium macrolide antibiotic active pharmaceutical ingredient manufactured to exacting British Pharmacopoeia and United States Pharmacopeia specifications. With CAS No. 1264-62-6 and molecular formula C43H75NO16, this compound delivers exceptional purity and reliability for pharmaceutical production needs. It functions as a critical component in developing effective antibiotic medications that combat diverse bacterial infections, specifically designed for manufacturers, importers, and distributors requiring consistent, bulk quantities of pharmaceutical-grade ingredients with guaranteed quality and performance characteristics.

This antibiotic API demonstrates extensive utility across multiple healthcare sectors including human pharmaceutical manufacturing, veterinary medicine production, and global export markets. Pharmaceutical manufacturers incorporate it into oral suspensions, tablets, and various dosage forms to address respiratory infections, dermatological conditions, and other bacterial diseases. Veterinary pharmaceutical producers integrate it into animal health solutions, while international companies value its adherence to worldwide quality standards for cross-border distribution and regulatory acceptance in diverse markets.

The commercial value of Erythromycin Ethyl Succinate lies in its proven reliability, quality consistency, and manufacturing flexibility. Organizations selecting this API benefit from minimized production risks, assured regulatory compliance, and adaptable order quantities to match production schedules. Its demonstrated efficacy in antibiotic formulations translates to superior end-products, enhanced customer satisfaction, and sustainable business relationships. The product's distinguishing advantages include rigorous quality control protocols, consistent batch performance, and responsiveness to specific client manufacturing requirements.

Key Features:
- Compliance with BP and USP pharmaceutical standards
- High purity macrolide antibiotic API composition
- Molecular weight of 862.05 for formulation accuracy
- CAS No. 1264-62-6 for identification and tracking
- Pharmaceutical grade quality assurance systems

Benefits:
- Regulatory compliance across international markets
- Consistent therapeutic performance in formulations
- Precise dosing capabilities in manufacturing processes
- Simplified inventory management and tracking
- Reduced production risks through quality assurance